2026 ICD-10-CM Diagnosis Code C60.8Malignant neoplasm of overlapping sites of penis
ICD-10-CM Codes›C00–D49›C60-C63›C60
- Billable — Valid for Submission
- Risk Adjusts — HCC 23
- Chronic Condition
C60.8 is a billable ICD-10-CM diagnosis code for malignant neoplasm of overlapping sites of penis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 715 through 716, 722 through 724. Coders also document this condition as overlapping malignant neoplasm of male genital organs. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Male reproductive system cancers - penis.
For Medicare Advantage risk adjustment, C60.8 maps to CMS-HCC Category 23 (Prostate, Breast, and Other Cancers and Tumors) under the V28 model, adding a risk factor of about 0.186 for a community, non-dual, aged beneficiary in payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
C60.8 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Overlapping malignant neoplasm of male genital organs
- Overlapping malignant neoplasm of penis
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| penis › overlapping sites | C60.8 | – | – | – | – | – |
Patient EducationClinical
Cancer
Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.
The full article covers:
- What is cancer?
- What are the types of cancer?
- How does cancer develop?
- What are the symptoms of cancer?
- How is cancer diagnosed?
- What are the treatments for cancer?
- Can cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C60.8 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C60.8Overview
What is the ICD-10 code for malignant neoplasm of overlapping sites of penis?
The ICD-10-CM code for malignant neoplasm of overlapping sites of penis is C60.8 (sometimes written as C608). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is C60.8 (Malignant neoplasm of penis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of overlapping sites of penis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C60.8 group to?
When malignant neoplasm of overlapping sites of penis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 715, 716, 722, 723, 724, with relative weights from 0.6117 to 2.2373 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C60.8?
Under the General Equivalence Mappings, malignant neoplasm of overlapping sites of penis converts to ICD-9-CM 187.8 (mal neo male genital NEC). The mapping is approximate, so confirm the match fits the documentation.
What HCC is C60.8?
C60.8 (malignant neoplasm of overlapping sites of penis) maps to CMS-HCC Category 23 (Prostate, Breast, and Other Cancers and Tumors), commonly written as HCC 23, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 12 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 22.
Does C60.8 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, C60.8 adds a risk adjustment factor of about 0.186 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.186 to 0.237 depending on the payment segment). A more severe related category (HCC 17, HCC 18, HCC 19, HCC 20, HCC 21, and HCC 22) supersedes it when both are reported. See the full factor table on the HCC 23 category page.
